Detalhe da pesquisa
1.
Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.
Hepatology
; 79(6): 1393-1400, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100294
2.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol
; 80(1): 20-30, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734683
3.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Clin Gastroenterol Hepatol
; 22(3): 572-580.e5, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734582
4.
Cost-effectiveness study of FIB-4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at-risk population.
Liver Int
; 44(4): 944-954, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291809
5.
Diagnostic performances of Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction-associated steatotic liver disease in Asian primary care clinics.
Hepatol Res
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703383
6.
Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort.
J Gastroenterol Hepatol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720448
7.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480009
8.
Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
Dig Dis Sci
; 69(5): 1701-1713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551744
9.
Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy.
Clin Gastroenterol Hepatol
; 21(4): 1041-1049.e3, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504562
10.
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Clin Gastroenterol Hepatol
; 21(4): 1013-1022.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654298
11.
A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
Am J Gastroenterol
; 118(5): 840-847, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305695
12.
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.
Am J Gastroenterol
; 118(11): 1963-1972, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881437
13.
Current and future treatment for alcoholic-related liver diseases.
J Gastroenterol Hepatol
; 38(8): 1218-1226, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300449
14.
Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis.
J Gastroenterol Hepatol
; 38(12): 2206-2214, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37811601
15.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
J Hepatol
; 76(2): 311-318, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606915
16.
Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers.
Antimicrob Agents Chemother
; 66(8): e0027522, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867571
17.
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 20(6): 1343-1353.e16, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500103
18.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089852
19.
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction-associated fatty liver disease in Korea.
Liver Int
; 42(7): 1536-1544, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338555
20.
Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era.
Hepatol Res
; 52(3): 247-254, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841632